Evoke Pharma GAAP EPS of -$0.62, revenue of $3.75M

Published 2 months ago Positive
Evoke Pharma GAAP EPS of -$0.62, revenue of $3.75M
Auto
* Evoke Pharma press release [https://seekingalpha.com/pr/20200753-evoke-pharma-reports-second-quarter-2025-financial-results-and-provides-business-update] (NASDAQ:EVOK [https://seekingalpha.com/symbol/EVOK]): Q2 GAAP EPS of -$0.62.
* Revenue of $3.75M (+47.1% Y/Y).

MORE ON EVOKE PHARMA

* Seeking Alpha’s Quant Rating on Evoke Pharma [https://seekingalpha.com/symbol/EVOK/ratings/quant-ratings]
* Historical earnings data for Evoke Pharma [https://seekingalpha.com/symbol/EVOK/earnings]
* Financial information for Evoke Pharma [https://seekingalpha.com/symbol/EVOK/income-statement]